We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Benicar MDL Plaintiffs Can't Depose Foreign Witnesses

Law360, New York (September 28, 2016, 8:36 PM EDT) -- Litigants suing over adverse effects of the blood pressure drug Benicar can’t compel testimony from employees of drugmaker Daiichi Sankyo's European unit, a New Jersey federal judge ruled Wednesday, citing the legal limits on deposing employees of a subsidiary that’s not a party to the case.

The plaintiffs in the centralized litigation had sought to depose the two highest-level members Daiichi Sankyo Europe GmbH’s Clinical Safety and Pharmacovigilance Department, who had extensive involvement in studying intestinal distress induced by olmesartan medoxomil, the drug branded as Benicar. The would-be...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.